$ cat ./records/gates-foundation-launches-75-million-child-health-and-mortality-s-2015.txt
Gates Foundation Launches $75 Million Child Health and Mortality Surveillance Network
[RECORD.TXT] · cat --full
The Gates Foundation committed up to $75 million to establish CHAMPS (Child Health and Mortality Prevention Surveillance), a minimum 20-year project to gather rigorous, laboratory-confirmed data on why children are dying in high-mortality regions of sub-Saharan Africa and South Asia. Led by Emory University's Global Health Institute with CDC technical support, CHAMPS deploys minimally invasive tissue sampling and molecular diagnostics to determine precise causes of death in children under five — data that had never existed at population scale before. The network can be rapidly repurposed for outbreak investigation during disease emergencies.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation Awards Johns Hopkins $525,000 to Evaluate Saliva-Based Non-Invasive Malaria Test
Next →
Gates Foundation Supports Modular B-LiFE Diagnostic Laboratory in Guinea
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.